Sarepta Therapeutics Inc (SRPT)
121.97
-1.10
(-0.89%)
USD |
NASDAQ |
Nov 05, 10:29
Sarepta Therapeutics Cash from Operations (Quarterly): 14.94M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.94M |
| March 31, 2024 | -242.08M |
| December 31, 2023 | -54.66M |
| September 30, 2023 | -114.71M |
| June 30, 2023 | -122.23M |
| March 31, 2023 | -209.40M |
| December 31, 2022 | -92.39M |
| September 30, 2022 | -64.96M |
| June 30, 2022 | -66.82M |
| March 31, 2022 | -101.18M |
| December 31, 2021 | -29.33M |
| September 30, 2021 | -124.33M |
| June 30, 2021 | -109.15M |
| March 31, 2021 | -180.37M |
| December 31, 2020 | -174.54M |
| September 30, 2020 | -238.19M |
| June 30, 2020 | -107.60M |
| March 31, 2020 | 627.79M |
| December 31, 2019 | -163.80M |
| September 30, 2019 | -67.43M |
| June 30, 2019 | -79.00M |
| March 31, 2019 | -146.23M |
| December 31, 2018 | -122.42M |
| September 30, 2018 | -113.32M |
| June 30, 2018 | -117.25M |
| Date | Value |
|---|---|
| March 31, 2018 | -35.67M |
| December 31, 2017 | -31.06M |
| September 30, 2017 | -57.90M |
| June 30, 2017 | -85.15M |
| March 31, 2017 | -57.89M |
| December 31, 2016 | -81.23M |
| September 30, 2016 | -60.62M |
| June 30, 2016 | -43.28M |
| March 31, 2016 | -60.69M |
| December 31, 2015 | -31.27M |
| September 30, 2015 | -46.31M |
| June 30, 2015 | -28.53M |
| March 31, 2015 | -43.35M |
| December 31, 2014 | -25.45M |
| September 30, 2014 | -35.32M |
| June 30, 2014 | -39.50M |
| March 31, 2014 | -28.26M |
| December 31, 2013 | -17.82M |
| September 30, 2013 | -19.88M |
| June 30, 2013 | -12.00M |
| March 31, 2013 | -14.99M |
| December 31, 2012 | -7.158M |
| September 30, 2012 | -7.805M |
| June 30, 2012 | -5.682M |
| March 31, 2012 | -9.049M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-242.08M
Minimum
Mar 2024
627.79M
Maximum
Mar 2020
-81.74M
Average
-109.15M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Regenxbio Inc | -45.50M |
| Catalyst Pharmaceuticals Inc | 64.14M |
| Vertex Pharmaceuticals Inc | -3.754B |
| Entrada Therapeutics Inc | 39.83M |
| Edgewise Therapeutics Inc | -26.10M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -98.53M |
| Cash from Financing (Quarterly) | 39.92M |
| Free Cash Flow | -527.92M |
| Free Cash Flow Per Share (Quarterly) | -0.1435 |
| Free Cash Flow to Equity (Quarterly) | -1.294M |
| Free Cash Flow to Firm (Quarterly) | -14.22M |
| Free Cash Flow Yield | -4.43% |